We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nanoscale Velcro Proteins Discovered to Be Used for Molecule Transport

By LabMedica International staff writers
Posted on 01 Jul 2014
Biologic membranes perform similar to a guarded border. More...
They separate the cell from their environment and at the same time control the coming and going of molecules. The nuclear membrane can be crossed via many tiny pores. Scientists have now discovered that proteins found within the nuclear pore function similar to a “Velcro” snap. They reported how these proteins can be used for controlled and selective transport of particles.

Scientists at the Biozentrum (Basel, Switzerland) and the Swiss Nanoscience Institute at the University of Basel (Switzerland), together with an international team of researchers, have published online June 15, 2014, in the journal Nature Nanotechnology, they reported how these proteins can be used for controlled and selective transport of particles.

Cells are always moving around. Many proteins, for example, need to travel from their production site in the cytoplasm to the nucleus, where they are used to read genetic information. Pores in the nuclear membrane enable their transport into and out of the cell nucleus. Prof. Roderick Lim, from the Biozentrum and the Swiss Nanoscience Institute at the University of Basel, studies the biophysic basics of this transport. To better determine this process, he has created a synthetic model of the nuclear pore complex, working with scientists from Lausanne (Switzerland) and Cambridge (UK), which has led to the discovery that its proteins function similar to a nanoscale Velcro, which can be used to transport tiniest particles.

Nuclear pores are protein complexes within the nuclear membrane that enables molecular exchange between the cytoplasm and nucleus. The major force is diffusion. Nuclear pores are lined with Velcro-like proteins. Only molecules specifically tagged with import proteins can bind to these proteins and therefore pass the pore. But for all nonbinding molecules, the nuclear pore acts as a barrier. The researchers hypothesized that transport depends on the strength of binding to the Velcro-like proteins. The binding should be just strong enough that molecules to be transported can bind but at the same time not too tight so that they can still diffuse through the pore.

In a synthetic system recreating the nuclear pore, the researchers assessed their therapy. They coated particles with import proteins and studied their behavior on the molecular Velcro. Surprisingly, the researchers discovered similarities in behavior to the Velcro strip’s features. On “clean Velcro,” the particles instantly adhere. However, when the Velcro is filled or “dirtied” import proteins, it is less sticky and the particles start to slide over its surface just by diffusion. “Understanding how the transport process functions in the nuclear pore complex was decisive for our discovery,” said Prof. Lim. “With the nanoscale Velcro we should be able to define the path to be taken as well as speed up the transport of selected particles without requiring external energy.”

Prof. Lim’s study of biomolecular transport mechanism form the foundation for the discovery of this amazing phenomenon that particles can be transported selectively with a molecular Velcro. His principle could find very practical applications, for instance as nanoscale conveyor belts, escalators, or tracks, explained Prof. Lim.

This could also potentially be applied to advanced miniaturize lab-on-chip technology, miniscule labs on chips, where this newly discovered approach to transporting would make modern complicated pump and valve systems a thing of the past, according to the scientists.

Related Links:

Biozentrum at the University of Basel 
Swiss Nanoscience Institute at the University of Basel



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.